Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0093 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |